Antimicrobial activity of ZnO-doxycycline hyclate thermosensitive gel

ScienceAsia

Volumn 38, Issue 1, 2012, Pages 64-74

  Phaechamud, Thawatchai ^a   Mahadlek, Jongjan ^a   Aroonrerk, Nuntana ^b   Choopun, Supab ^c   Charoenteeraboon, Juree ^a  

^a SILPAKORN UNIVERSITY   (Thailand)

^b SRINAKHARINWIROT UNIVERSITY   (Thailand)

^c CHIANG MAI UNIVERSITY   (Thailand)

Author keywords

N methyl 2 pyrrolidone; Periodontitis therapy

Indexed keywords

EID: 84860636047     PISSN: 15131874     EISSN: None     Source Type: Journal    
DOI: 10.2306/scienceasia1513-1874.2012.38.064     Document Type: Article

References (47)

1. Sawai J, Kawada E, Kanou F, Igarashi H, Hashimoto A, Kokugan T, Shimizu M (1996) Detection of active oxygen generated from ceramic powders having antibacterial activity. J Chem Eng Jpn 29, 627-33. (Pubitemid 126539307)
2. Khattar JA, Musharrafieh M, Tamim H (2007) Topical zinc oxide versus salicylic acid-lactic acid combination in the treatment of warts. Int J Dermatol 46, 427-30. (Pubitemid 46585402)
3. Barnard AS, Xiao Y, Cai Z (2006) Modelling the shape and orientation of ZnO nanobelts. Chem Phys Lett 419, 313-6. (Pubitemid 43220485)
4. Coleman NJ, Bishop AH, Booth SE, Nicholson JW (2009) Ag+-and Zn2+-exchange kinetics and antimicrobial properties of 11Å tobermorites. J Eur Ceram Soc 29, 1109-17.
5. He L, Liu Y, Mustapha A, Lin M (2011) Antifungal activity of zinc oxide nanoparticles against Botrytis cinerea and Penicillium expansum. Microbiol Res 166, 207-15.
6. Eskandari M, Haghighi N, Ahmadi V, Haghighi F, Mohammadi SH (2011) Growth and investigation of antifungal properties of ZnO nanorod arrays on the glass. Physica B 406, 112-4.
7. Yamamoto O, Hotta M, Sawai J, Nakagawa Z (1998) Influence of powder characteristic of ZnO on antibacterial activity - effect of specific surface area. J Ceram Soc Jpn Int Ed 106, 1007-11. (Pubitemid 128575903)
8. Stoirrmenov PK, Klinger RL, Marchin GL, Klabunde KJ (2002) Metal oxide nanoparticles as bactericidal agents. Langmuir 18, 6679-86. (Pubitemid 35383306)
9. Olivieri L, Seiller M, Bromberg L, Besnard M, Duong T N L, Grossiord JL (2003) Optimization of a thermally reversible W/O/W multiple emulsion for shear-induced drug release. J Contr Release 88, 401-12. (Pubitemid 36331882)
10. Choi H, Lee M, Kim M, Kim CK (1999) Effect of additives on the physicochemical properties of liquid suppository bases. Int J Pharm 190, 13-9. (Pubitemid 29467467)
11. Yong CS, Choi J, Quan QZ, Rhee JD, Kim CK, Lim SJ (2001) Effect of sodium chloride on the gelation temperature, gel strength and bioadhesive force of poloxamer gels containing diclofenac sodium. Int J Pharm 226, 195-205. (Pubitemid 32800794)
12. Mahadlek J, Charoenteeraboon J, Choopun S, Phaechamud T (2010) Role of zinc oxide on rheology of thermosensitive gel developed for periodontitis treatment. Adv Mater Res 93-94, 479-84.
13. Stratton CW, Lorian V (1996) Mechanisms of action for antimicrobial agents: general principals and mechanisms for selected classes of antibiotics. In: Antibiotic in Laboratory Medicine, 4th edn, Williams & Wilkins, Baltimore.
14. Ravivarapu HB, Moyer KL, Dunn RL (2000) Sustained suppression of pituitary-gonadal axis with and injection, in situ forming implant of leuprolide acetate. J Pharmaceut Sci 89, 732-41.
15. Hansen CM, Just L (2001) Prediction of environmental stress cracking in plastics with Hansen solubility parameters. Ind Eng Chem Res 40, 21-5. (Pubitemid 32059921)
16. Akhter S, Barry BW (1985) Absorption through human skin of ibuprofen and flurbiprofen; effect of dose variation, deposited drug film, occlusion and the penetration enhancer N-methyl-2-pyrrolidone. J Pharm Pharmacol 37, 27-37. (Pubitemid 15189943)
17. Sasaki H, Kojima M, Mori Y, Nakamura J, Shibasaki J (1988) Enhancing effect of pyrrolidone derivatives on transdermal drug delivery I. Int J Pharm 44, 15-24.
18. Koizumi A, Fujii M, Kondoh M, Watanabe Y (2004) Effect of N-methyl-2-pyrrolidone on skin permeation of estradiol. Eur J Pharm Biopharm 57, 473-8. (Pubitemid 38490564)
19. Polson AM, Garrett S, Stoller NH, Bandt CL, Hanes PJ, Killoy WJ, et al (1997) Multi-center comparative evaluation of subgingivally delivered sanguinarine and doxycycline in the treatment of periodontitis. II. Clinical results. J Periodontol 68, 119-26. (Pubitemid 27149465)
20. Kranz H, Bodmeier R (2008) Structure formation and characterization of injectable drug loaded biodegradable devices: In situ implants versus in situ microparticles. Eur J Pharmaceut Sci 34, 164-72.
21. Hongsith H, Chairuangsri T, Phaechamud T, Choopun S (2009) Growth kinetic and characterization of tetrapod ZnO nanostructures. Solid State Comm 149, 1184-7.
22. Schmolka IR (1972) Artificial skin I. Preparation and properties of pluronic F-127 gels for treatment of burns. J Biomed Mater Res 6, 571-82.
23. Wang JX, Wen LX, Wang ZH, Chen JF (2006) Immobilization of silver on hollow silica nanospheres and nanotubes and their antibacterial effects. Mater Chem Phys 96, 90-7.
24. NCCLS (2000) Performance standards for antimicrobial disk susceptibility tests. Approved standard, 7th edn, NCCLS document M2-A7. NCCLS, Wayne, Pa.
25. CLSI 2010 (Clinical and Laboratory Standards Institute) (2010) Performance standards for antimicrobial susceptibility testing. Twentieth information supplement. M100-S20. Wayne, PA.
26. Tipton DA, Flynn JC, Stein SH, Dabbous M (2003) Cyclooxygenase-2 inhibitors decrease interleukin-1beta-stimulated prostaglandin E2 and IL-6 production by human gingival fibroblasts. J Periodontol 74, 1754-63. (Pubitemid 38181217)
27. Denizot F, Lang R (1986) Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Meth 89, 271-7. (Pubitemid 16080782)
28. Bloomfield VA (2000) Static and dynamic light scattering from aggregating particles. Biopolymers 54, 168-72. (Pubitemid 30482316)
29. Yamamoto O (2001) Influence of particle size on the antibacterial activity of zinc oxide. Int J Inorg Mater 3, 643-6. (Pubitemid 33150686)
30. Brayner R, Ferrari-Iliou N, Bravois N (2006) Toxicological impact studies based on Escherichia coli bacteria in ultrafine ZnO nanoparticles colloid medium. Nano Lett 6, 866-70.
31. Cassanho A C A, Fernandes AM, Oliveira LD, Carvalho C A T, Jorge A O C, Koga-Ito CY (2005) In vitro activity of zinc oxide-eugenol and glass ionomer cements on Candida albicans. Braz Oral Res 19, 134-8.
32. Yamamoto O, Iida Y (2003) Antifungal characteristics of spherical carbon materials with zinc oxide. J Ceram Soc Jpn Int Ed 111, 614-6.
33. Tam KH, Djurišic AB, Chan CM, Xi YY, Tse CW, Leung YH (2008) Antibacterial activity of ZnO nanorods prepared by a hydrothermal method. Thin Solid Films 516, 6167-74.
34. Junior SJ, Favieri A, Gahyva SM, Moraes SR, Lima KC, Lopes HP (2000) Antimicrobial activity and flow rate of newer and established root canal sealers. J Endod 26, 274-7.
35. Sawai J, Shoji S, Igarashi H, Hashimoto A, Kokugan T, Shimizu M, Kojima H (1998) Hydrogen peroxide as an antibacterial factor in zinc oxide powder slurry. J Ferment Bioeng 86, 521-2. (Pubitemid 29008746)
36. Brayner R, Ferrari-Iliou R, Brivois N, Djediat S, Benedetti MF, Fiévet F (2006) Toxicological impact studies based on Escherichia coli bacteria in ultrafine ZnO nanoparticles colloidal medium. Nano Lett 6, 866-70.
37. Scherrer R, Gerhardt P (1971) Molecular sieving by the Bacillus megaterium cell wall and protoplast. J Bacteriol 107, 718-35.
38. Fu G, Vary PS, Lin CT (2005) Anatase TiO2 nanocomposites for antimicrobial coatings. J Phys Chem B 109, 8889-98. (Pubitemid 40750925)
39. Zhang L, Ding Y, Povey M, York D (2008) ZnO nanofluids - A potential antibacterial agent. Progr Nat Sci 18, 939-44.
40. Padmavathy N, Vijayaraghavan R (2008) Enhanced bioactivity of ZnO nanoparticles - an antimicrobial study. Sci Tech Adv Mater 9, 1-7.
41. Maheshwari M, Paradkar A, Yamamura S, Kadam S (2006) Preparation and characterization of pluroniccolloidal silicon dioxide composite particles as liquid crystal precursor. AAPS PharmSciTech 7, E1-7. (Pubitemid 44867028)
42. Ravivarapu HB, Moyer KL, Dunn RL (2000) Sustained suppression of pituitary-gonadal axis with and injection, in situ forming implant of leuprolide acetate. J Pharmaceut Sci 89, 732-41.
43. Saillenfait AM, Gallissot F, Morel G (2003) Developmental toxicity of N-methyl-2-pyrrolidone in rats following inhalation exposure. Food Chem Toxicol 41, 583-8. (Pubitemid 36259795)
44. Saillenfait AM, Gallissot F, Langonne I, Sabate JP (2002) Developmental toxicity of N-methyl-2-pyrrolidone administered orally to rats. Food Chem Toxicol 40, 1705-12.
45. Hansen CM, Just L (2001) Prediction of environmental stress cracking in plastics with Hansen solubility. Ind Eng Chem Res 40, 21-5. (Pubitemid 32059921)
46. Novak-Pekli M, Mesbah ME, Petho G (1996) Equilibrium studies on tetracycline-metal ion systems. J Pharmaceut Biomed Anal 14, 1025-9. (Pubitemid 26235152)
47. Babich H, Babich JP (1997) Sodium lauryl sulfate and triclosan: in vitro cytotoxicity studies with gingival cells. Toxicol Lett 91, 189-96. (Pubitemid 27263443)